103 results
Page 5 of 6
8-K
EX-1.1
i0t ln4v23fk
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-99.1
ijfu0ogxrne3 rui
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-99.1
rgakk178
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
ayvpc566p bzbaqhpbhp
12 Jun 18
Viking Therapeutics Announces Closing of Public Offering of Common Stock
7:10am
8-K
EX-1.1
ep5jj2575k
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
8-K
EX-99.1
vstbga
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
8-K
EX-99.1
99m21w7
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
u19jgb
8 Apr 16
Prospectus supplement with pricing info
12:00am